Robert M. Cohen

997 total citations
15 papers, 754 citations indexed

About

Robert M. Cohen is a scholar working on Pharmacology, Psychiatry and Mental health and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Robert M. Cohen has authored 15 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 5 papers in Psychiatry and Mental health and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Robert M. Cohen's work include Treatment of Major Depression (5 papers), Medical Imaging Techniques and Applications (3 papers) and Attention Deficit Hyperactivity Disorder (3 papers). Robert M. Cohen is often cited by papers focused on Treatment of Major Depression (5 papers), Medical Imaging Techniques and Applications (3 papers) and Attention Deficit Hyperactivity Disorder (3 papers). Robert M. Cohen collaborates with scholars based in United States, Sweden and Netherlands. Robert M. Cohen's co-authors include Alan J. Zametkin, John A. Matochik, Monique Ernst, Peter H. Jons, Waguih William IsHak, Jared M. Greenberg, Anna C. King, William E. Semple, Thomas Nordahl and Trey Sunderland and has published in prestigious journals such as Journal of Neuroscience, Neuropsychopharmacology and Journal of Cerebral Blood Flow & Metabolism.

In The Last Decade

Robert M. Cohen

15 papers receiving 732 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert M. Cohen United States 13 397 272 173 157 101 15 754
Eva Hilger Austria 18 252 0.6× 141 0.5× 238 1.4× 147 0.9× 70 0.7× 35 948
Klaus-Peter Kühl Germany 13 264 0.7× 204 0.8× 76 0.4× 116 0.7× 74 0.7× 20 667
C. Wurthmann Germany 11 311 0.8× 196 0.7× 172 1.0× 94 0.6× 32 0.3× 27 733
Marie‐France Poirier France 17 412 1.0× 200 0.7× 195 1.1× 168 1.1× 100 1.0× 34 964
David A. Cousins United Kingdom 14 436 1.1× 219 0.8× 97 0.6× 71 0.5× 73 0.7× 35 751
Isabel Martínez‐Gras Spain 15 277 0.7× 146 0.5× 175 1.0× 132 0.8× 39 0.4× 35 725
Dimitrios Kontis Greece 17 415 1.0× 194 0.7× 150 0.9× 91 0.6× 45 0.4× 35 899
Murat İlhan Atagün Türkiye 15 401 1.0× 276 1.0× 113 0.7× 67 0.4× 41 0.4× 64 813
Jaana Föhr Finland 12 207 0.5× 221 0.8× 372 2.2× 195 1.2× 44 0.4× 21 953
Anna Mané Spain 18 583 1.5× 222 0.8× 89 0.5× 106 0.7× 49 0.5× 70 902

Countries citing papers authored by Robert M. Cohen

Since Specialization
Citations

This map shows the geographic impact of Robert M. Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert M. Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert M. Cohen more than expected).

Fields of papers citing papers by Robert M. Cohen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert M. Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert M. Cohen. The network helps show where Robert M. Cohen may publish in the future.

Co-authorship network of co-authors of Robert M. Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Robert M. Cohen. A scholar is included among the top collaborators of Robert M. Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert M. Cohen. Robert M. Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Saré, Rachel Michelle, et al.. (2020). Behavioral Phenotype in the TgF344-AD Rat Model of Alzheimer’s Disease. Frontiers in Neuroscience. 14. 601–601. 39 indexed citations
2.
Rentsendorj, Altan, Armen Mardiros, Nicole Yeager, et al.. (2020). Functional recreation of age-related CD8 T cells in young mice identifies drivers of aging- and human-specific tissue pathology. Mechanisms of Ageing and Development. 191. 111351–111351. 6 indexed citations
3.
IsHak, Waguih William, David M. James, James Mirocha, et al.. (2016). Patient-reported functioning in major depressive disorder. Therapeutic Advances in Chronic Disease. 7(3). 160–169. 51 indexed citations
4.
IsHak, Waguih William, et al.. (2014). Patient-reported outcomes before and after treatment of major depressive disorder.. PubMed. 16(2). 171–83. 31 indexed citations
6.
Kepe, Vladimir, Mateen Moghbel, Bengt Långström, et al.. (2013). Amyloid-β Positron Emission Tomography Imaging Probes: A Critical Review. Journal of Alzheimer s Disease. 36(4). 613–631. 71 indexed citations
7.
Ichise, Masanori, Robert M. Cohen, & Richard E. Carson. (2007). Noninvasive Estimation of Normalized Distribution Volume: Application to the Muscarinic-2 Ligand [18F]FP-TZTP. Journal of Cerebral Blood Flow & Metabolism. 28(2). 420–430. 17 indexed citations
8.
Cannon-Spoor, H. Eleanor, James A. Levy, George S. Zubenko, et al.. (2005). Effects of Previous Major Depressive Illness on Cognition in Alzheimer Disease Patients. American Journal of Geriatric Psychiatry. 13(4). 312–318. 15 indexed citations
9.
Ernst, Monique, Alan J. Zametkin, John A. Matochik, Peter H. Jons, & Robert M. Cohen. (1998). DOPA Decarboxylase Activity in Attention Deficit Hyperactivity Disorder Adults. A [Fluorine-18]Fluorodopa Positron Emission Tomographic Study. Journal of Neuroscience. 18(15). 5901–5907. 254 indexed citations
10.
Ernst, Monique, et al.. (1996). Selegiline in adults with attention deficit hyperactivity disorder: clinical efficacy and safety.. PubMed. 32(3). 327–34. 30 indexed citations
11.
Matochik, John A., Thomas Nordahl, Michael Groß, et al.. (1993). Effects of Acute Stimulant Medication on Cerebral Metabolism in Adults with Hyperactivity. Neuropsychopharmacology. 8(4). 377–386. 81 indexed citations
12.
Doudet, Doris J., Thomas Aigner, Catherine A. McLellan, & Robert M. Cohen. (1992). Positron emission tomography with 18F-DOPA: Interpretation and biological correlates in nonhuman primates. Psychiatry Research Neuroimaging. 45(3). 153–168. 12 indexed citations
13.
Doudet, Doris J., Catherine A. McLellan, Thomas Aigner, Richard Jed Wyatt, & Robert M. Cohen. (1992). Delayed L-phenylalanine infusion allows for simultaneous kinetic analysis and improved evaluation of specific-to-nonspecific fluorine-18-dopa uptake in brain.. PubMed. 33(7). 1383–9. 12 indexed citations
14.
Cohen, Robert M., et al.. (1988). Effectiveness of a nurse-managed program for children with chronic asthma.. PubMed. 3(5). 312–7. 34 indexed citations
15.
Murphy, Dennis L., Trey Sunderland, & Robert M. Cohen. (1984). Monoamine Oxidase-Inhibiting Antidepressants: A Clinical Update. Psychiatric Clinics of North America. 7(3). 549–562. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026